The laboratory panel to assess liver impairment in CVID includes full blood count, liver function tests – LFTs (i.e., AST, ALT, ALP, γGT, total protein, and albumin) and clotting profile (i.e., INR, APTT, fibrinogen). The gene discussed is ALB; the disease is common variable immunodeficiency.